RecruitingNCT05845801

Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer


Sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Enrollment

3,000 participants

Start Date

Dec 7, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study is building a registry of younger adults (55 and under) who have been diagnosed with pancreatic cancer. The goal is to better understand why pancreatic cancer occurs at a younger age, and to collect data that could lead to earlier detection and better treatments. **You may be eligible if...** - You are between 18 and 55 years old at the time of your pancreatic cancer diagnosis - You have been diagnosed with pancreatic cancer (specifically pancreatic ductal adenocarcinoma) - You are willing to provide written consent **You may NOT be eligible if...** - You have a different type of pancreatic tumor (such as neuroendocrine tumors, cholangiocarcinoma, or ampullary cancer) - You are under 18 or over 55 at the time of diagnosis - You are unwilling or unable to give consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRegister

Prospective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.


Locations(1)

AOUI Verona

Verona, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05845801


Related Trials